Mechanism of action of brexpiprazole: comparison with aripiprazole.

Abstract

Brexpiprazole is a new therapeutic agent that was recently approved for the treatment of schizophrenia and for the adjunctive treatment of major depressive disorder. Brexpiprazole has features that both overlap and contrast with a related molecule, aripiprazole, and these features are discussed here.

DOI: 10.1017/S1092852915000954

5 Figures and Tables

01000200020162017
Citations per Year

653 Citations

Semantic Scholar estimates that this publication has 653 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Stahl2016MechanismOA, title={Mechanism of action of brexpiprazole: comparison with aripiprazole.}, author={Stephen M. Stahl}, journal={CNS spectrums}, year={2016}, volume={21 1}, pages={1-6} }